Expect Prime Day to be even bigger this year.
Not every industry is software-driven.
Cardiologist and genomic-medicine expert Eric Topol makes his case for a future of “medical selfies.”
Raising millions, Editas proved that investors are enthusiastic about gene editing. Now the company has to make its technology work.
Thirteen years after the human genome was sequenced, some remarkable treatments are being developed.
Herceptin, the original genetic drug, showed that not all cancers are alike.
His startup is using data to unlock the connections between DNA and illness.
Same-day grocery delivery is a notoriously difficult business, but Instacart believes it’s found a way to make money.
Startups focused on Asia are among those aiming to bring precision medicine to far more people.
Extraterrestrial ventures are no longer limited to deep-pocketed tycoons.